223 related articles for article (PubMed ID: 32288656)
1. Exacerbations of chronic obstructive pulmonary disease and chronic mucus hypersecretion.
Tesfaigzi Y; Meek P; Lareau S
Clin Appl Immunol Rev; 2006; 6(1):21-36. PubMed ID: 32288656
[TBL] [Abstract][Full Text] [Related]
2. Exacerbations of chronic obstructive pulmonary disease.
Wedzicha JA; Donaldson GC
Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
[TBL] [Abstract][Full Text] [Related]
3. Increased Expression of
Manevski M; Devadoss D; Long C; Singh SP; Nasser MW; Borchert GM; Nair MN; Rahman I; Sopori M; Chand HS
Front Immunol; 2022; 13():803362. PubMed ID: 35774797
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic antibiotics for adults with chronic obstructive pulmonary disease: a network meta-analysis.
Janjua S; Mathioudakis AG; Fortescue R; Walker RA; Sharif S; Threapleton CJ; Dias S
Cochrane Database Syst Rev; 2021 Jan; 1(1):CD013198. PubMed ID: 33448349
[TBL] [Abstract][Full Text] [Related]
5. Effect of chronic mucus hypersecretion on treatment responses to inhaled therapies in patients with chronic obstructive pulmonary disease: Post hoc analysis of the IMPACT trial.
Thompson PJ; Criner GJ; Dransfield MT; Halpin DMG; Han MK; Lipson DA; Maghzal GJ; Martinez FJ; Midwinter D; Singh D; Tombs L; Wise RA
Respirology; 2022 Dec; 27(12):1034-1044. PubMed ID: 35970518
[TBL] [Abstract][Full Text] [Related]
6. Mucous hypersecretion and relationship to cough.
Nadel JA
Pulm Pharmacol Ther; 2013 Oct; 26(5):510-3. PubMed ID: 23434445
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
Herath SC; Normansell R; Maisey S; Poole P
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD009764. PubMed ID: 30376188
[TBL] [Abstract][Full Text] [Related]
8. Remodeling in response to infection and injury. Airway inflammation and hypersecretion of mucus in smoking subjects with chronic obstructive pulmonary disease.
Maestrelli P; Saetta M; Mapp CE; Fabbri LM
Am J Respir Crit Care Med; 2001 Nov; 164(10 Pt 2):S76-80. PubMed ID: 11734472
[TBL] [Abstract][Full Text] [Related]
9. Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease.
Poole P; Sathananthan K; Fortescue R
Cochrane Database Syst Rev; 2019 May; 5(5):CD001287. PubMed ID: 31107966
[TBL] [Abstract][Full Text] [Related]
10. Mucus hypersecretion in chronic obstructive pulmonary disease.
Rogers DF
Novartis Found Symp; 2001; 234():65-77; discussion 77-83. PubMed ID: 11199104
[TBL] [Abstract][Full Text] [Related]
11. Influence of coexistence of mild OSA on airway mucus hypersecretion in patients with COPD.
Wan N; Tang X; Ding H; Yan Y; Zhuang Y; Qi C; Chen Q; Xie W; Zhang J; Wang Y; Liang M; Ning W; Cao J
J Breath Res; 2021 Feb; 15(2):. PubMed ID: 33339013
[TBL] [Abstract][Full Text] [Related]
12. Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT.
Devereux G; Cotton S; Fielding S; McMeekin N; Barnes PJ; Briggs A; Burns G; Chaudhuri R; Chrystyn H; Davies L; Soyza A; Gompertz S; Haughney J; Innes K; Kaniewska J; Lee A; Morice A; Norrie J; Sullivan A; Wilson A; Price D
Health Technol Assess; 2019 Jul; 23(37):1-146. PubMed ID: 31343402
[TBL] [Abstract][Full Text] [Related]
13. [Effects of simvastatin on airway inflammation and airway mucus hypersecretion in rats with chronic obstructive pulmonary disease].
Wang S; Xiong L; Deng X; Ren W; Zhu C; Li C; Zhou Q
Zhonghua Yi Xue Za Zhi; 2015 Jun; 95(22):1726-30. PubMed ID: 26704155
[TBL] [Abstract][Full Text] [Related]
14. Respiratory syncytial virus inhibits ciliagenesis in differentiated normal human bronchial epithelial cells: effectiveness of N-acetylcysteine.
Mata M; Sarrion I; Armengot M; Carda C; Martinez I; Melero JA; Cortijo J
PLoS One; 2012; 7(10):e48037. PubMed ID: 23118923
[TBL] [Abstract][Full Text] [Related]
15. Defining Chronic Mucus Hypersecretion Using the CAT in the SPIROMICS Cohort.
Stott-Miller M; Müllerová H; Miller B; Tabberer M; El Baou C; Keeley T; Martinez FJ; Han M; Dransfield M; Hansel NN; Cooper CB; Woodruff P; Ortega VE; Comellas AP; Paine Iii R; Kanner RE; Anderson W; Drummond MB; Kim V; Tal-Singer R; Lazaar AL
Int J Chron Obstruct Pulmon Dis; 2020; 15():2467-2476. PubMed ID: 33116463
[TBL] [Abstract][Full Text] [Related]
16. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease.
Seemungal T; Harper-Owen R; Bhowmik A; Moric I; Sanderson G; Message S; Maccallum P; Meade TW; Jeffries DJ; Johnston SL; Wedzicha JA
Am J Respir Crit Care Med; 2001 Nov; 164(9):1618-23. PubMed ID: 11719299
[TBL] [Abstract][Full Text] [Related]
17. New pharmacotherapy for airway mucus hypersecretion in asthma and COPD: targeting intracellular signaling pathways.
Lai H; Rogers DF
J Aerosol Med Pulm Drug Deliv; 2010 Aug; 23(4):219-31. PubMed ID: 20695774
[TBL] [Abstract][Full Text] [Related]
18. Advances in mucous cell metaplasia: a plug for mucus as a therapeutic focus in chronic airway disease.
Curran DR; Cohn L
Am J Respir Cell Mol Biol; 2010 Mar; 42(3):268-75. PubMed ID: 19520914
[TBL] [Abstract][Full Text] [Related]
19. Effect of high/low dose N-acetylcysteine on chronic obstructive pulmonary disease: a systematic review and meta-analysis.
Shen Y; Cai W; Lei S; Zhang Z
COPD; 2014 Jun; 11(3):351-8. PubMed ID: 24378052
[TBL] [Abstract][Full Text] [Related]
20. Chronic mucus hypersecretion in COPD and death from pulmonary infection.
Prescott E; Lange P; Vestbo J
Eur Respir J; 1995 Aug; 8(8):1333-8. PubMed ID: 7489800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
